Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charise Gleason

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Cancer|June 22, 2010
Bortezomib, thalidomide, and dexamethasone as induction therapy for patients with symptomatic multiple myeloma: a retrospective studyJonathan L Kaufman, Ajay Nooka, Mark Vrana, et al.
Clinical Journal of Oncology Nursing|September 26, 2017
Distress, Fatigue, and Sexuality: Understanding and Treating Concerns and Symptoms in Patients With Multiple Myeloma 
Donna Catamero, Kimberly Noonan, Tiffany Richards, et al.
Journal of Oncology Practice|July 12, 2018
Managing Infusion Reactions to New Monoclonal Antibodies in Multiple Myeloma: Daratumumab and ElotuzumabAjay K Nooka, Charise Gleason, Marva Ollivierre Sargeant, et al.
Cancer Medicine|April 28, 2016
Lack of health maintenance examinations and risk in myeloma patientsJoseph D Tariman, Charise Gleason, Beth Faiman, et al.
Cancer|May 16, 2019
Clinical efficacy of daratumumab, pomalidomide, and dexamethasone in patients with relapsed or refractory myeloma: Utility of re-treatment with daratumumab among refractory patientsAjay K Nooka, Nisha S Joseph, Jonathan L Kaufman, et al.
Cancer|September 6, 2013
Bortezomib-containing induction regimens in transplant-eligible myeloma patients: a meta-analysis of phase 3 randomized clinical trialsAjay K Nooka, Jonathan L Kaufman, Madhusmita Behera, et al.
Clinical Lymphoma, Myeloma & Leukemia|April 5, 2020
Consensus Recommendations for the Clinical Management of Patients With Multiple Myeloma Treated With SelinexorJoseph Mikhael, Kimberly R Noonan, Beth Faiman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 16, 2013
Antimicrobial prophylaxis and outpatient management of fever and neutropenia in adults treated for malignancy: American Society of Clinical Oncology clinical practice guidelineChristopher R Flowers, Jerome Seidenfeld, Eric J Bow, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 21, 2018
Outpatient Management of Fever and Neutropenia in Adults Treated for Malignancy: American Society of Clinical Oncology and Infectious Diseases Society of America Clinical Practice Guideline UpdateRandy A Taplitz, Erin B Kennedy, Eric J Bow, et al.
Cancer|October 18, 2018
Survival outcomes of patients with primary plasma cell leukemia (pPCL) treated with novel agentsRoberto Mina, Nisha S Joseph, Jonathan L Kaufman, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Cancer|June 22, 2010
Bortezomib, thalidomide, and dexamethasone as induction therapy for patients with symptomatic multiple myeloma: a retrospective studyJonathan L Kaufman, Ajay Nooka, Mark Vrana, et al.
Clinical Journal of Oncology Nursing|September 26, 2017
Distress, Fatigue, and Sexuality: Understanding and Treating Concerns and Symptoms in Patients With Multiple Myeloma 
Donna Catamero, Kimberly Noonan, Tiffany Richards, et al.
Journal of Oncology Practice|July 12, 2018
Managing Infusion Reactions to New Monoclonal Antibodies in Multiple Myeloma: Daratumumab and ElotuzumabAjay K Nooka, Charise Gleason, Marva Ollivierre Sargeant, et al.
Cancer Medicine|April 28, 2016
Lack of health maintenance examinations and risk in myeloma patientsJoseph D Tariman, Charise Gleason, Beth Faiman, et al.
Cancer|May 16, 2019
Clinical efficacy of daratumumab, pomalidomide, and dexamethasone in patients with relapsed or refractory myeloma: Utility of re-treatment with daratumumab among refractory patientsAjay K Nooka, Nisha S Joseph, Jonathan L Kaufman, et al.
Cancer|September 6, 2013
Bortezomib-containing induction regimens in transplant-eligible myeloma patients: a meta-analysis of phase 3 randomized clinical trialsAjay K Nooka, Jonathan L Kaufman, Madhusmita Behera, et al.
Clinical Lymphoma, Myeloma & Leukemia|April 5, 2020
Consensus Recommendations for the Clinical Management of Patients With Multiple Myeloma Treated With SelinexorJoseph Mikhael, Kimberly R Noonan, Beth Faiman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 16, 2013
Antimicrobial prophylaxis and outpatient management of fever and neutropenia in adults treated for malignancy: American Society of Clinical Oncology clinical practice guidelineChristopher R Flowers, Jerome Seidenfeld, Eric J Bow, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 21, 2018
Outpatient Management of Fever and Neutropenia in Adults Treated for Malignancy: American Society of Clinical Oncology and Infectious Diseases Society of America Clinical Practice Guideline UpdateRandy A Taplitz, Erin B Kennedy, Eric J Bow, et al.
Cancer|October 18, 2018
Survival outcomes of patients with primary plasma cell leukemia (pPCL) treated with novel agentsRoberto Mina, Nisha S Joseph, Jonathan L Kaufman, et al.
Pageof 3